<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-09-05" modified="2020-10-07" version="160">
<accession>Q8NB16</accession>
<accession>A6NCE4</accession>
<accession>Q8N6V0</accession>
<name>MLKL_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="22">Mixed lineage kinase domain-like protein</fullName>
<shortName evidence="18">hMLKL</shortName>
</recommendedName>
</protein>
<gene>
<name type="primary" evidence="21 26">MLKL</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1" evidence="22">
<citation type="journal article" date="2002" name="Science" volume="298" first="1912" last="1934">
<title>The protein kinase complement of the human genome.</title>
<authorList>
<person name="Manning G."/>
<person name="Whyte D.B."/>
<person name="Martinez R."/>
<person name="Hunter T."/>
<person name="Sudarsanam S."/>
</authorList>
<dbReference type="PubMed" id="12471243"/>
<dbReference type="DOI" id="10.1126/science.1075762"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>NOMENCLATURE</scope>
</reference>
<reference key="2" evidence="22 25">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue evidence="25">Chondrocyte</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nature" volume="432" first="988" last="994">
<title>The sequence and analysis of duplication-rich human chromosome 16.</title>
<authorList>
<person name="Martin J."/>
<person name="Han C."/>
<person name="Gordon L.A."/>
<person name="Terry A."/>
<person name="Prabhakar S."/>
<person name="She X."/>
<person name="Xie G."/>
<person name="Hellsten U."/>
<person name="Chan Y.M."/>
<person name="Altherr M."/>
<person name="Couronne O."/>
<person name="Aerts A."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Blumer H."/>
<person name="Branscomb E."/>
<person name="Brown N.C."/>
<person name="Bruno W.J."/>
<person name="Buckingham J.M."/>
<person name="Callen D.F."/>
<person name="Campbell C.S."/>
<person name="Campbell M.L."/>
<person name="Campbell E.W."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chasteen L.A."/>
<person name="Chertkov O."/>
<person name="Chi H.C."/>
<person name="Christensen M."/>
<person name="Clark L.M."/>
<person name="Cohn J.D."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Dickson M."/>
<person name="Dimitrijevic-Bussod M."/>
<person name="Escobar J."/>
<person name="Fawcett J.J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Goodwin L.A."/>
<person name="Grady D.L."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Hildebrand C.E."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Jewett P.B."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Krawczyk M.-C."/>
<person name="Leyba T."/>
<person name="Longmire J.L."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Ludeman T."/>
<person name="Manohar C.F."/>
<person name="Mark G.A."/>
<person name="McMurray K.L."/>
<person name="Meincke L.J."/>
<person name="Morgan J."/>
<person name="Moyzis R.K."/>
<person name="Mundt M.O."/>
<person name="Munk A.C."/>
<person name="Nandkeshwar R.D."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Parson-Quintana B."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Ricke D.O."/>
<person name="Robinson D.L."/>
<person name="Rodriguez A."/>
<person name="Salamov A."/>
<person name="Saunders E.H."/>
<person name="Scott D."/>
<person name="Shough T."/>
<person name="Stallings R.L."/>
<person name="Stalvey M."/>
<person name="Sutherland R.D."/>
<person name="Tapia R."/>
<person name="Tesmer J.G."/>
<person name="Thayer N."/>
<person name="Thompson L.S."/>
<person name="Tice H."/>
<person name="Torney D.C."/>
<person name="Tran-Gyamfi M."/>
<person name="Tsai M."/>
<person name="Ulanovsky L.E."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="White P.S."/>
<person name="Williams A.L."/>
<person name="Wills P.L."/>
<person name="Wu J.-R."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="DeJong P."/>
<person name="Bruce D."/>
<person name="Doggett N.A."/>
<person name="Deaven L."/>
<person name="Schmutz J."/>
<person name="Grimwood J."/>
<person name="Richardson P."/>
<person name="Rokhsar D.S."/>
<person name="Eichler E.E."/>
<person name="Gilna P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Pennacchio L.A."/>
</authorList>
<dbReference type="PubMed" id="15616553"/>
<dbReference type="DOI" id="10.1038/nature03187"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4" evidence="22 24">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue evidence="24">Leukocyte</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2012" name="Cell" volume="148" first="213" last="227">
<title>Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase.</title>
<authorList>
<person name="Sun L."/>
<person name="Wang H."/>
<person name="Wang Z."/>
<person name="He S."/>
<person name="Chen S."/>
<person name="Liao D."/>
<person name="Wang L."/>
<person name="Yan J."/>
<person name="Liu W."/>
<person name="Lei X."/>
<person name="Wang X."/>
</authorList>
<dbReference type="PubMed" id="22265413"/>
<dbReference type="DOI" id="10.1016/j.cell.2011.11.031"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RIPK3</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>PHOSPHORYLATION AT THR-357 AND SER-358</scope>
<scope>MUTAGENESIS OF CYS-86; THR-357 AND SER-358</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2012" name="Cell" volume="148" first="228" last="243">
<title>The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways.</title>
<authorList>
<person name="Wang Z."/>
<person name="Jiang H."/>
<person name="Chen S."/>
<person name="Du F."/>
<person name="Wang X."/>
</authorList>
<dbReference type="PubMed" id="22265414"/>
<dbReference type="DOI" id="10.1016/j.cell.2011.11.030"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN COMPLEX WITH PGAM5; RIPK1 AND RIPK3</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="5322" last="5327">
<title>Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis.</title>
<authorList>
<person name="Zhao J."/>
<person name="Jitkaew S."/>
<person name="Cai Z."/>
<person name="Choksi S."/>
<person name="Li Q."/>
<person name="Luo J."/>
<person name="Liu Z.G."/>
</authorList>
<dbReference type="PubMed" id="22421439"/>
<dbReference type="DOI" id="10.1073/pnas.1200012109"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RIPK3</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2014" name="Nat. Cell Biol." volume="16" first="55" last="65">
<title>Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis.</title>
<authorList>
<person name="Cai Z."/>
<person name="Jitkaew S."/>
<person name="Zhao J."/>
<person name="Chiang H.C."/>
<person name="Choksi S."/>
<person name="Liu J."/>
<person name="Ward Y."/>
<person name="Wu L.G."/>
<person name="Liu Z.G."/>
</authorList>
<dbReference type="PubMed" id="24316671"/>
<dbReference type="DOI" id="10.1038/ncb2883"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF LEU-58; ILE-76; LEU-162 AND LEU-165</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2018" name="Mol. Cell" volume="70" first="920" last="935">
<title>PELI1 selectively targets kinase-active RIP3 for ubiquitylation-dependent proteasomal degradation.</title>
<authorList>
<person name="Choi S.W."/>
<person name="Park H.H."/>
<person name="Kim S."/>
<person name="Chung J.M."/>
<person name="Noh H.J."/>
<person name="Kim S.K."/>
<person name="Song H.K."/>
<person name="Lee C.W."/>
<person name="Morgan M.J."/>
<person name="Kang H.C."/>
<person name="Kim Y.S."/>
</authorList>
<dbReference type="PubMed" id="29883609"/>
<dbReference type="DOI" id="10.1016/j.molcel.2018.05.016"/>
</citation>
<scope>INTERACTION WITH RIPK3</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2018" name="Mol. Cell" volume="70" first="936" last="948">
<title>MLKL requires the inositol phosphate code to execute necroptosis.</title>
<authorList>
<person name="Dovey C.M."/>
<person name="Diep J."/>
<person name="Clarke B.P."/>
<person name="Hale A.T."/>
<person name="McNamara D.E."/>
<person name="Guo H."/>
<person name="Brown N.W. Jr."/>
<person name="Cao J.Y."/>
<person name="Grace C.R."/>
<person name="Gough P.J."/>
<person name="Bertin J."/>
<person name="Dixon S.J."/>
<person name="Fiedler D."/>
<person name="Mocarski E.S."/>
<person name="Kaiser W.J."/>
<person name="Moldoveanu T."/>
<person name="York J.D."/>
<person name="Carette J.E."/>
</authorList>
<dbReference type="PubMed" id="29883610"/>
<dbReference type="DOI" id="10.1016/j.molcel.2018.05.010"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>PHOSPHORYLATION AT SER-358</scope>
<scope>SUBUNIT</scope>
<scope>REGION NBB</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2014" name="Biochem. J." volume="457" first="369" last="377">
<title>Insights into the evolution of divergent nucleotide-binding mechanisms among pseudokinases revealed by crystal structures of human and mouse MLKL.</title>
<authorList>
<person name="Murphy J.M."/>
<person name="Lucet I.S."/>
<person name="Hildebrand J.M."/>
<person name="Tanzer M.C."/>
<person name="Young S.N."/>
<person name="Sharma P."/>
<person name="Lessene G."/>
<person name="Alexander W.S."/>
<person name="Babon J.J."/>
<person name="Silke J."/>
<person name="Czabotar P.E."/>
</authorList>
<dbReference type="PubMed" id="24219132"/>
<dbReference type="DOI" id="10.1042/bj20131270"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 189-471</scope>
<scope>ATP-BINDING</scope>
<scope>MUTAGENESIS OF LYS-230; LYS-331 AND GLU-351</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2013" name="Cell Rep." volume="5" first="70" last="78">
<title>Structural insights into RIP3-mediated necroptotic signaling.</title>
<authorList>
<person name="Xie T."/>
<person name="Peng W."/>
<person name="Yan C."/>
<person name="Wu J."/>
<person name="Gong X."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="24095729"/>
<dbReference type="DOI" id="10.1016/j.celrep.2013.08.044"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 179-471</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] THR-52; GLU-100; PRO-132; GLN-146; LEU-169; PRO-291; MET-364; ILE-398 AND HIS-421</scope>
</reference>
<comment type="function">
<text evidence="7 11 12 13 15 17">Pseudokinase that plays a key role in TNF-induced necroptosis, a programmed cell death process (PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:24316671). Does not have protein kinase activity (PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:24316671). Activated following phosphorylation by RIPK3, leading to homotrimerization, localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane damage (PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:24316671). In addition to TNF-induced necroptosis, necroptosis can also take place in the nucleus in response to orthomyxoviruses infection: following activation by ZBP1, MLKL is phosphorylated by RIPK3 in the nucleus, triggering disruption of the nuclear envelope and leakage of cellular DNA into the cytosol.following ZBP1 activation, which senses double-stranded Z-RNA structures, nuclear RIPK3 catalyzes phosphorylation and activation of MLKL, promoting disruption of the nuclear envelope and leakage of cellular DNA into the cytosol (By similarity). Binds to highly phosphorylated inositol phosphates such as inositolhexakisphosphate (InsP6) which is essential for its necroptotic function (PubMed:29883610).</text>
</comment>
<comment type="activity regulation">
<text evidence="11 17">Activated via binding to highly phosphorylated inositol phosphates such as inositolhexakisphosphate (InsP6) which mediates the release of an N-terminal auto-inhibitory region (PubMed:29883610). Activation requires not only RIPK3-dependent phosphorylation but also binding to highly phosphorylated inositol phosphates (PubMed:29883610). Inhibited by necrosulfonamide, a specific inhibitor of necroptosis that targets Cys-86 (PubMed:22265413).</text>
</comment>
<comment type="subunit">
<text evidence="11 12 13 15 16 17">Homooligomer (PubMed:29883610). Homotrimer; forms homotrimers on necroptosis induction (PubMed:24316671). Upon TNF-induced necrosis, forms in complex with PGAM5, RIPK1 and RIPK3 (PubMed:22265414). Within this complex, may play a role in the proper targeting of RIPK1-RIPK3 to its downstream effector PGAM5 (PubMed:22265414). Interacts with RIPK3; the interaction is direct and promotes its phosphorylation and subsequent activation (PubMed:22265413, PubMed:22421439, PubMed:29883609).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1055040">
<id>Q8NB16</id>
</interactant>
<interactant intactId="EBI-298250">
<id>Q9Y572</id>
<label>RIPK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-16084674">
<id>Q8NB16-1</id>
</interactant>
<interactant intactId="EBI-16084674">
<id>Q8NB16-1</id>
<label>MLKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-19046912">
<id>Q8NB16-2</id>
</interactant>
<interactant intactId="EBI-372273">
<id>P20618</id>
<label>PSMB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-19046912">
<id>Q8NB16-2</id>
</interactant>
<interactant intactId="EBI-717048">
<id>P60903</id>
<label>S100A10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="15">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15 17">Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="7">Nucleus</location>
</subcellularLocation>
<text evidence="7 15">Localizes to the cytoplasm and translocates to the plasma membrane on necroptosis induction (PubMed:24316671). Localizes to the nucleus in response to orthomyxoviruses infection (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q8NB16-1</id>
<name evidence="18 19">1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q8NB16-2</id>
<name evidence="20">2</name>
<sequence type="described" ref="VSP_052133 VSP_052134"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="7">The protein kinase domain is catalytically inactive but contains an unusual pseudoactive site with an interaction between Lys-230 and Gln-356 residues (By similarity). Upon phosphorylation by RIPK3, undergoes an active conformation (By similarity).</text>
</comment>
<comment type="domain">
<text evidence="15">The coiled coil region 2 is responsible for homotrimerization.</text>
</comment>
<comment type="PTM">
<text evidence="11">Phosphorylation by RIPK3 induces a conformational switch that is required for necroptosis (PubMed:22265413). It also induces homotrimerization and localization to the plasma membrane (PubMed:22265413).</text>
</comment>
<comment type="miscellaneous">
<text evidence="23">Interaction with RIPK3 is species specific: human MLKL only interacts with human RIPK3 and not mouse RIPK3.</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the protein kinase superfamily.</text>
</comment>
<dbReference type="EMBL" id="AK091708">
<property type="protein sequence ID" value="BAC03728.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC109599">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC028141">
<property type="protein sequence ID" value="AAH28141.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS32487.1">
<molecule id="Q8NB16-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45528.1">
<molecule id="Q8NB16-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001135969.1">
<molecule id="Q8NB16-2"/>
<property type="nucleotide sequence ID" value="NM_001142497.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_689862.1">
<molecule id="Q8NB16-1"/>
<property type="nucleotide sequence ID" value="NM_152649.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005255891.1">
<molecule id="Q8NB16-1"/>
<property type="nucleotide sequence ID" value="XM_005255834.3"/>
</dbReference>
<dbReference type="PDB" id="2MSV">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-154"/>
</dbReference>
<dbReference type="PDB" id="4M67">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=179-471"/>
</dbReference>
<dbReference type="PDB" id="4MWI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=183-471"/>
</dbReference>
<dbReference type="PDB" id="5KNJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.88"/>
<property type="chains" value="A/B=191-471"/>
</dbReference>
<dbReference type="PDB" id="5KO1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.16"/>
<property type="chains" value="A=191-471"/>
</dbReference>
<dbReference type="PDB" id="6BWK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="A=190-471"/>
</dbReference>
<dbReference type="PDB" id="6D74">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-156"/>
</dbReference>
<dbReference type="PDB" id="6UX8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=5-154"/>
</dbReference>
<dbReference type="PDBsum" id="2MSV"/>
<dbReference type="PDBsum" id="4M67"/>
<dbReference type="PDBsum" id="4MWI"/>
<dbReference type="PDBsum" id="5KNJ"/>
<dbReference type="PDBsum" id="5KO1"/>
<dbReference type="PDBsum" id="6BWK"/>
<dbReference type="PDBsum" id="6D74"/>
<dbReference type="PDBsum" id="6UX8"/>
<dbReference type="BMRB" id="Q8NB16"/>
<dbReference type="SMR" id="Q8NB16"/>
<dbReference type="BioGRID" id="128244">
<property type="interactions" value="20"/>
</dbReference>
<dbReference type="DIP" id="DIP-41782N"/>
<dbReference type="IntAct" id="Q8NB16">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="MINT" id="Q8NB16"/>
<dbReference type="STRING" id="9606.ENSP00000308351"/>
<dbReference type="ChEMBL" id="CHEMBL1938217"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2106"/>
<dbReference type="TCDB" id="1.A.105.1.1">
<property type="family name" value="the mixed lineage kinase domain-like (mlkl) family"/>
</dbReference>
<dbReference type="iPTMnet" id="Q8NB16"/>
<dbReference type="PhosphoSitePlus" id="Q8NB16"/>
<dbReference type="BioMuta" id="MLKL"/>
<dbReference type="DMDM" id="74762545"/>
<dbReference type="CPTAC" id="CPTAC-895"/>
<dbReference type="CPTAC" id="CPTAC-896"/>
<dbReference type="EPD" id="Q8NB16"/>
<dbReference type="jPOST" id="Q8NB16"/>
<dbReference type="MassIVE" id="Q8NB16"/>
<dbReference type="MaxQB" id="Q8NB16"/>
<dbReference type="PaxDb" id="Q8NB16"/>
<dbReference type="PeptideAtlas" id="Q8NB16"/>
<dbReference type="PRIDE" id="Q8NB16"/>
<dbReference type="ProteomicsDB" id="72718">
<molecule id="Q8NB16-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="72719">
<molecule id="Q8NB16-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="2097">
<property type="antibodies" value="326 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="197259"/>
<dbReference type="Ensembl" id="ENST00000306247">
<molecule id="Q8NB16-2"/>
<property type="protein sequence ID" value="ENSP00000303118"/>
<property type="gene ID" value="ENSG00000168404"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000308807">
<molecule id="Q8NB16-1"/>
<property type="protein sequence ID" value="ENSP00000308351"/>
<property type="gene ID" value="ENSG00000168404"/>
</dbReference>
<dbReference type="GeneID" id="197259"/>
<dbReference type="KEGG" id="hsa:197259"/>
<dbReference type="UCSC" id="uc002fdb.3">
<molecule id="Q8NB16-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="197259"/>
<dbReference type="DisGeNET" id="197259"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000168404.12"/>
<dbReference type="GeneCards" id="MLKL"/>
<dbReference type="HGNC" id="HGNC:26617">
<property type="gene designation" value="MLKL"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000168404">
<property type="expression patterns" value="Tissue enhanced (vagina)"/>
</dbReference>
<dbReference type="MIM" id="615153">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8NB16"/>
<dbReference type="OpenTargets" id="ENSG00000168404"/>
<dbReference type="PharmGKB" id="PA142671349"/>
<dbReference type="eggNOG" id="KOG0192">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000016453"/>
<dbReference type="HOGENOM" id="CLU_044216_0_0_1"/>
<dbReference type="InParanoid" id="Q8NB16"/>
<dbReference type="KO" id="K08849"/>
<dbReference type="OMA" id="WQQEDQQ"/>
<dbReference type="OrthoDB" id="1388260at2759"/>
<dbReference type="PhylomeDB" id="Q8NB16"/>
<dbReference type="TreeFam" id="TF328453"/>
<dbReference type="PathwayCommons" id="Q8NB16"/>
<dbReference type="Reactome" id="R-HSA-3295583">
<property type="pathway name" value="TRP channels"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5213460">
<property type="pathway name" value="RIPK1-mediated regulated necrosis"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="197259">
<property type="hits" value="3 hits in 900 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MLKL">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GenomeRNAi" id="197259"/>
<dbReference type="Pharos" id="Q8NB16">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q8NB16"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="RNAct" id="Q8NB16">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000168404">
<property type="expression patterns" value="Expressed in granulocyte and 200 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q8NB16">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q8NB16">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0004706">
<property type="term" value="F:JUN kinase kinase kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007257">
<property type="term" value="P:activation of JUN kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097528">
<property type="term" value="P:execution phase of necroptosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070266">
<property type="term" value="P:necroptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097527">
<property type="term" value="P:necroptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070207">
<property type="term" value="P:protein homotrimerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.930.20">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR036537">
<property type="entry name" value="Adaptor_Cbl_N_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="PK_Tyr_Ser-Thr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-1210">Necrosis</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="chain" description="Mixed lineage kinase domain-like protein" id="PRO_0000248239">
<location>
<begin position="1"/>
<end position="471"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="9">
<location>
<begin position="194"/>
<end position="469"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="9">
<location>
<begin position="209"/>
<end position="217"/>
</location>
</feature>
<feature type="region of interest" description="N-terminal bundle and brace (NBB); mediates INSP6 binding" evidence="17">
<location>
<begin position="1"/>
<end position="149"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="8">
<location>
<begin position="55"/>
<end position="84"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="8">
<location>
<begin position="139"/>
<end position="180"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="22">
<location>
<position position="230"/>
</location>
</feature>
<feature type="site" description="Target of necrosulfonamide inhibitor" evidence="11">
<location>
<position position="86"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6">
<location>
<position position="125"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by RIPK3" evidence="11">
<location>
<position position="357"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RIPK3" evidence="11 17">
<location>
<position position="358"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RIPK3" evidence="7">
<location>
<position position="360"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_052133" evidence="20">
<original>YLPPKCMQEIPQEQIKEIKKEQLSGSP</original>
<variation>SLESSSGKSPLEISRFKVKNVKTGSAS</variation>
<location>
<begin position="179"/>
<end position="205"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_052134" evidence="20">
<location>
<begin position="206"/>
<end position="413"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34251827." id="VAR_041350" evidence="10">
<original>S</original>
<variation>T</variation>
<location>
<position position="52"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs33987771." id="VAR_041351" evidence="10">
<original>D</original>
<variation>E</variation>
<location>
<position position="100"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35589326." id="VAR_041352" evidence="10">
<original>S</original>
<variation>P</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34515646." id="VAR_041353" evidence="10">
<original>R</original>
<variation>Q</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55929310." id="VAR_041354" evidence="10">
<original>M</original>
<variation>L</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric adenocarcinoma sample; somatic mutation; dbSNP:rs1313508921." id="VAR_041355" evidence="10">
<original>L</original>
<variation>P</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34389205." id="VAR_041356" evidence="10">
<original>T</original>
<variation>M</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric adenocarcinoma sample; somatic mutation." id="VAR_041357" evidence="10">
<original>F</original>
<variation>I</variation>
<location>
<position position="398"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55987292." id="VAR_041358" evidence="10">
<original>R</original>
<variation>H</variation>
<location>
<position position="421"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect formation of homotrimers, while translocation to the plasma membrane on necroptosis induction is impaired; when associated with G-76." evidence="15">
<original>L</original>
<variation>G</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect formation of homotrimers, while translocation to the plasma membrane on necroptosis induction is impaired; when associated with G-58." evidence="15">
<original>I</original>
<variation>G</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to necrosulfonamide inhibitor." evidence="11">
<original>C</original>
<variation>S</variation>
<location>
<position position="86"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs formation of homotrimers and translocation to the plasma membrane on necroptosis induction; when associated with G-165." evidence="15">
<original>L</original>
<variation>G</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs formation of homotrimers and translocation to the plasma membrane on necroptosis induction; when associated with G-162." evidence="15">
<original>L</original>
<variation>G</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ATP-binding." evidence="14">
<original>K</original>
<variation>M</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs ATP-binding." evidence="14">
<original>K</original>
<variation>N</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="mutagenesis site" description="Binds ATP with an enhanced affinity." evidence="14">
<original>E</original>
<variation>K</variation>
<location>
<position position="351"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimics phosphorylation state; acts as a dominant-negative mutant that impairs necroptosis.">
<original>TS</original>
<variation>ED</variation>
<location>
<begin position="357"/>
<end position="358"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect. Abolishes ability to mediate necroptosis; when associated with A-358." evidence="11">
<original>T</original>
<variation>A</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect. Abolishes ability to mediate necroptosis; when associated with A-357." evidence="11">
<original>S</original>
<variation>A</variation>
<location>
<position position="358"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="5"/>
<end position="20"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="22"/>
<end position="24"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="25"/>
<end position="47"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="56"/>
<end position="78"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="82"/>
<end position="89"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="93"/>
<end position="96"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="99"/>
<end position="118"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="128"/>
<end position="132"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="133"/>
<end position="149"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="198"/>
<end position="201"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="202"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="207"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="213"/>
<end position="222"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="225"/>
<end position="232"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="240"/>
<end position="256"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="265"/>
<end position="271"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="274"/>
<end position="276"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="278"/>
<end position="284"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="291"/>
<end position="297"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="303"/>
<end position="322"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="323"/>
<end position="325"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="334"/>
<end position="336"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="337"/>
<end position="339"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="345"/>
<end position="347"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="373"/>
<end position="376"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="379"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="391"/>
<end position="407"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="411"/>
<end position="414"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="417"/>
<end position="425"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="439"/>
<end position="448"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="453"/>
<end position="455"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="459"/>
<end position="467"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2MSV"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4MWI"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5KNJ"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6UX8"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9D2Y4"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255"/>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22265413"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22265414"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22421439"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24219132"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24316671"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29883609"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29883610"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12471243"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="22265413"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<evidence key="23" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22265413"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAH28141.1"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="BAC03728.1"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:26617"/>
</source>
</evidence>
<sequence length="471" mass="54479" checksum="005E7F7AB6D20649" modified="2002-10-01" version="1">MENLKHIITLGQVIHKRCEEMKYCKKQCRRLGHRVLGLIKPLEMLQDQGKRSVPSEKLTTAMNRFKAALEEANGEIEKFSNRSNICRFLTASQDKILFKDVNRKLSDVWKELSLLLQVEQRMPVSPISQGASWAQEDQQDADEDRRAFQMLRRDNEKIEASLRRLEINMKEIKETLRQYLPPKCMQEIPQEQIKEIKKEQLSGSPWILLRENEVSTLYKGEYHRAPVAIKVFKKLQAGSIAIVRQTFNKEIKTMKKFESPNILRIFGICIDETVTPPQFSIVMEYCELGTLRELLDREKDLTLGKRMVLVLGAARGLYRLHHSEAPELHGKIRSSNFLVTQGYQVKLAGFELRKTQTSMSLGTTREKTDRVKSTAYLSPQELEDVFYQYDVKSEIYSFGIVLWEIATGDIPFQGCNSEKIRKLVAVKRQQEPLGEDCPSELREIIDECRAHDPSVRPSVDEILKKLSTFSK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

